Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives
Use of combined oral contraceptives (OC) is associated with a significant risk of thrombosis. The mechanisms of this effect are not clearly defined. Tissue factor pathway inhibitor (TFPI) is a circulating anti‐coagulant that inhibits the earliest steps in activation of the extrinsic coagulation path...
Saved in:
Published in | American journal of hematology Vol. 60; no. 3; pp. 175 - 180 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
New York
John Wiley & Sons, Inc
01.03.1999
Wiley-Liss |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!